Pacific Biosciences of California, Inc.

PACB · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$55,370$179,911$325,089$460,725
Short-Term Investments$334,561$451,505$447,229$583,675
Receivables$27,524$36,615$18,786$24,241
Inventory$58,755$56,676$50,381$24,599
Other Curr. Assets$19,471$17,340$10,589$7,894
Total Curr. Assets$495,681$742,047$852,074$1,101,134
Property Plant & Equip (Net)$46,596$69,025$81,343$79,121
Goodwill$317,761$462,261$409,974$409,974
Intangibles$389,572$456,984$410,245$410,979
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$10,837$15,696$13,450$5,762
Total NC Assets$764,766$1,003,966$915,012$905,836
Other Assets$0$0$0$0
Total Assets$1,260,447$1,746,013$1,767,086$2,006,970
Liabilities
Payables$16,590$15,062$12,028$11,002
Short-Term Debt$10,026$10,081$10,728$9,318
Tax Payable$0$0$0$0
Deferred Revenue$13,864$16,342$30,498$10,977
Other Curr. Liab.$25,819$53,544$210,081$40,412
Total Curr. Liab.$66,299$95,029$263,335$71,709
LT Debt$662,408$923,849$937,753$946,037
Deferred Rev, NC$5,900$5,530$1,794$25,049
Deferred Tax Liab, NC$0$0$0-$25,049
Other NC Liab.$19,246$20,301$1,300$198,237
Total NC Liab.$687,554$949,680$940,847$1,144,274
Other Liabilities$0$0$0$0
Cap. Leases$24,940$41,197$49,956$57,680
Total Liabilities$753,853$1,044,709$1,204,182$1,215,983
Equity
Pref Stock$0$0$0$0
Common Stock$294$268$227$221
Retained Earnings-$2,148,926-$1,839,075-$1,532,340-$1,218,092
AOCI$422$219-$4,765-$1,087
Other Equity$2,654,804$2,539,892$2,099,782$2,009,945
Total Equity$506,594$701,304$562,904$790,987
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$1,260,447$1,746,013$1,767,086$2,006,970
Net Debt$617,064$754,019$623,392$494,630
Pacific Biosciences of California, Inc. (PACB) Financial Statements & Key Stats | AlphaPilot